LAVA-051

· Lava Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LAVA-051, covering 2025-01-27 to 2025-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML [Phase 1]